Allosteric modulators for
human health
About us
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Addex Corporate Presentation
Pipeline
Research And Development
Clinical and Pre-Clinical Pipeline
Publications
Technology platform
Allosteric modulation
Our capabilities
Screening Assays
Chemistry
Partners & collaboration
Investors
Stock Data
Downloads
Register for email news
News Events & Careers
Press releases
Events
Careers
Research And Development
Dipraglurant-IR for PD-LID
Dipraglurant-ER for dystonia
ADX71149 for epilepsy
GABAB PAM for Addiction
GABAB PAM for CMT1A
Back
mGlu7 NAM for PTSD
mGlu2 NAM for mild neurocognitive disorders
mGlu4 PAM for Parkinson’s disease
mGlu3 PAM for neurodegenerative disorders
